Compound Detail
CHEMBL5095303
VUTRISIRAN SODIUM 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
No structure available
Basic Information
| ChEMBL ID | CHEMBL5095303 |
| Name | VUTRISIRAN SODIUM |
| Phase | Approved |
| Structure Type | NONE |
| Therapeutic | ✓ Yes |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
5
Known Names
2
Indications
1
Mechanisms
Drug Information
| Molecule Type | Oligonucleotide |
| First Approval | 2022 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Transthyretin mRNA rnai inhibitor | RNAI INHIBITOR | Transthyretin mRNA | ✓ | ✓ |
Indications
Amyloid Neuropathies, Familial Polyneuropathies
Data from ChEMBL 36 via Core Engine